As a case in point, BMP4 was identified as a compelling candidate molecule promoting NB cell line differentiation, exhibiting the capacity to decrease expression of CD15 and CD184 antigens as well as the neuroblast marker DCX and malignancy-associated NMYC, while simultaneously enhancing TrkA expression. The gene discussed is NTRK1; the disease is neuroblastoma.